Ventricular bigeminy associated with voriconazole, methadone and esomeprazole

International Journal of Clinical Pharmacy

Volumn 33, Issue 6, 2011, Pages 905-908

  Scholler, Julie ^a   Nivoix, Yasmine ^a   Herbrecht, Raoul ^a   Kemmel, Véronique ^a   Levêque, Dominique ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Bigeminy; Drug drug interaction; Esomeprazole; Methadone; Voriconazole

Indexed keywords

AMIKACIN; ESOMEPRAZOLE; IMIPENEM; LEVOFLOXACIN; METHADONE; VANCOMYCIN; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BLOOD ANALYSIS; CARDIOTOXICITY; CASE REPORT; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; HEART VENTRICLE BIGEMINY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INVASIVE ASPERGILLOSIS; PRIORITY JOURNAL; QUANTITATIVE STUDY; REMISSION;

ADULT; ANALGESICS, OPIOID; ANTIFUNGAL AGENTS; ARRHYTHMIAS, CARDIAC; DRUG INTERACTIONS; FEMALE; HUMANS; METHADONE; OMEPRAZOLE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTON PUMP INHIBITORS; PYRIMIDINES; TRIAZOLES; VENTRICULAR DYSFUNCTION;

EID: 83255193887     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-011-9581-3     Document Type: Article

References (10)

1. Ehret GB, Desmeules JA, Broers B. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned from pharmacology. Expert Opin Drug Saf. 2007;6:289-303. (Pubitemid 46767636)
2. Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology. 2008;108:363-74. (Pubitemid 351304229)
3. Levêque D, Nivoix Y, Jehl F, Herbrecht R. Clinical pharmacokinetics of voriconazole. Int J Antimicrob Agents. 2006;27: 274-84.
4. Jeong S, Nguyen PD, Desta Z. Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes; major effects of CYPs 2B6, 2C9, 2C19, and 3A4. Antimicrob Agents Chemother. 2009;53:541-51.
5. A ̈belöA, Andersson TB, Antonsson M, Naudot AK, Skanberg I, Weidolf L. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes. Drug Metab Dispos. 2000;28:966-72. (Pubitemid 30612617)
6. Li XQ, Andersson TB, Ahlström M, Weidolf L. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lanzoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos. 2004;32:821-7. (Pubitemid 38955611)
7. Liu P, Foster G, LaBadie R, Somoza E, Sharma A. Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy. Antimicrob Agents Chemother. 2007;51:110-8. (Pubitemid 46047695)
8. Wood N, Tan K, Purkins L, Layton G, Hamlin J, Kleinermans D, Nichols D. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. Br J Clin Pharmacol. 2003;56 Suppl 1:56-61. (Pubitemid 37491735)
9. Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46:201-11. (Pubitemid 351269158)
10. Falagas ME, Rafailidis PI, Rosmarakis ES. Arrhythmias associated with fluoroquinolone therapy. Int J Antimicrob Agents. 2007;29:374-9. (Pubitemid 46349590)